2004 Journal Article Permeability studies of alkylamides and caffeic acid conjugates from echinacea using a Caco-2 cell monolayer modelMatthias, A., Blanchfield, J. T., Penman, K. G., Toth, I., Lang, C. S., De Voss, J. J. and Lehmann, R. P. (2004). Permeability studies of alkylamides and caffeic acid conjugates from echinacea using a Caco-2 cell monolayer model. Journal of Clinical Pharmacy And Therapeutics, 29 (1), 7-13. doi: 10.1046/j.1365-2710.2003.00530.x |
2004 Conference Publication Novel vaccine delivery systemsToth, I. (2004). Novel vaccine delivery systems. GPEN 2004, Kyoto, 26-28 May, 2004. |
2004 Journal Article Nucleophilic substitution reactions of pyranose polytosylatesMcGeary, R. P., Rasoul Amini, S., Tang, V. W. S. and Toth, I. (2004). Nucleophilic substitution reactions of pyranose polytosylates. Journal of Organic Chemistry, 69 (8), 2727-2730. doi: 10.1021/jo035779k |
2004 Journal Article Design, Synthesis, and Evaluation of a Liposaccharide Drug Delivery Agent: Application to the Gastrointestinal Absorption of GentamicinRoss, B. P., DeCruz, S. E., Lynch, T. B., Davis-Goff, K. and Toth, I. (2004). Design, Synthesis, and Evaluation of a Liposaccharide Drug Delivery Agent: Application to the Gastrointestinal Absorption of Gentamicin. Journal of Medicinal Chemistry, 47 (5), 1251-1258. doi: 10.1021/jm030474j |
2004 Conference Publication Lipid and carbohydrate based macromolecules in drug and vaccine deliveryToth, I., Horvath, A., Blanchfield, J. T., Olive, C., Good, M. F., Wimmer, N. and Rakoczy, E.P. (2004). Lipid and carbohydrate based macromolecules in drug and vaccine delivery. 18th American Peptide Symposium, Boston, 19-23 July, 2004. |
2004 Journal Article Lipid core peptide technology and group A streptococcal vaccine deliveryOlive, C., Batzloff, M.R. and Toth, I. (2004). Lipid core peptide technology and group A streptococcal vaccine delivery. Expert Review of Vaccines, 3 (1), 43-58. doi: 10.1586/14760584.3.1.43 |
2004 Conference Publication A novel liposaccharide system for the delivery of Endormorphin 1Koda, Y., Blanchfield, J. T., Okada, Y. and Toth, I. (2004). A novel liposaccharide system for the delivery of Endormorphin 1. PSWC 2004, Kyoto, 29 May- 3 June, 2004. |
2004 Conference Publication Incorporation of lipoamino acids - peptide conjugates within liposomes: Effect of alkyl chain length, number of alkyl chains and method of liposome preparationLiang, M.T., Davies, N. M. and Toth, I. (2004). Incorporation of lipoamino acids - peptide conjugates within liposomes: Effect of alkyl chain length, number of alkyl chains and method of liposome preparation. Annual Conference of the APSA, 2004, Melbourne, Vic, Australia, 4-7 December, 2004. Mount Waverley, Victoria: Australasian Pharmaceutical Science Association. |
2004 Journal Article Mucosal immunization: Adjuvants and delivery systemsMoyle, P.M., McGeary, R. P., Blanchfield, J. T. and Toth, I. (2004). Mucosal immunization: Adjuvants and delivery systems. Current Drug Delivery, 1 (4), 385-396. doi: 10.2174/1567201043334588 |
2004 Conference Publication Preparation of peptide functionalized nanoparticles by interfacial polymerisation of w/o microemulsionsLiang, M. T., Davies, N. M. and Toth, I. (2004). Preparation of peptide functionalized nanoparticles by interfacial polymerisation of w/o microemulsions. CTP 2004, Brisbane, 1-6 Aug 2004. Australia: Blackwell Publishing Asia. |
2003 Edited Outputs Mini-Reviews in Medicinal ChemistryMini-Reviews in Medicinal Chemistry. (2003). 3 (7) |
2003 Journal Article Development of lipid-core-peptide (LCP) based vaccines for the prevention of the group A streptococcal (GAS) infectionMoyle, P. M., Horvath, A., Olive, C., Good, M. F. and Toth, I. (2003). Development of lipid-core-peptide (LCP) based vaccines for the prevention of the group A streptococcal (GAS) infection. Letters In Peptide Science, 10 (5-6), 605-613. doi: 10.1007/BF02442594 |
2003 Journal Article Transdermal delivery of a tetrapeptide: Evaluation of passive diffusionBenson, Heather A. E., Caccetta, Rima, Chen, Yan, Kearns, Philip and Toth, Istvan (2003). Transdermal delivery of a tetrapeptide: Evaluation of passive diffusion. Letters in Peptide Science, 10 (5-6), 615-620. doi: 10.1007/BF02442595 |
2003 Journal Article Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogensOlive, Colleen, Batzloff, Michael, Horvath, Aniko, Clair, Timothy, Yarwood, Penny, Toth, Istvan and Good, Michael F. (2003). Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens. Infection And Immunity, 71 (5), 2373-2383. doi: 10.1128/IAI.71.5.2373-2383.2003 |
2003 Journal Article Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of α-conotoxin MIIBlanchfield, J. T., Dutton, J. T., Hogg, R. C., Gallagher, O. P., Craik, D. J., Jones, A., Adams, D. J., Lewis, R. J., Alewood, P. F. and Toth, I. (2003). Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of α-conotoxin MII. Journal of Medicinal Chemistry, 46 (7), 1266-1272. doi: 10.1021/jm020426j |
2003 Journal Article A new principle for tight junction modulation based on occludin peptidesTavelin, S., Hashimoto, K., Malkinson, J., Lazorova, L., Toth, I. and Artursson, P. (2003). A new principle for tight junction modulation based on occludin peptides. Molecular Pharmacology, 64 (6), 1530-1540. doi: 10.1124/mol.64.6.1530 |
2003 Journal Article Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failureRussell, F. D., Meyers, D. E., Galbraith, A., Bett, N., Toth, I., Kearns, P. S. and Molenaar, P. (2003). Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure. American Journal of Physiology - Heart & Circulatory Physiology, 285 (Oct.2003), H1576-H1581. doi: 10.1152/ajpheart.00217.2003 |
2003 Book Chapter Drug delivery systems utilizing lipids and sugarsWong, A., Bender, V. and Toth, I. (2003). Drug delivery systems utilizing lipids and sugars. Molecular Pathomechanisms and New Trends in Drug Research. (pp. 599-612) edited by G. Keri and I. Toth. London & New York: Taylor & Francis. doi: 10.1201/9780203219973.ch45 |
2003 Conference Publication Lipid and carbohydrate based macromolecules in drug and vaccine deliveryToth, I., Horvath, A., Blanchfield, J. T., Olive, C., Good, M. F., Wimmer, N. and Rakoczy, E. P. (2003). Lipid and carbohydrate based macromolecules in drug and vaccine delivery. Brisbane Biological and Organic Chemistry Symposium, Gold Coast, 28 November, 2003. |
2003 Conference Publication Oligonucleotide gene therapy for choroidal neovascularisation enhanced by dendrimer mediated deliveryMarano, R. J., Wimmer, N., Kearns, P. S., Thomas, B. G., Toth, I., Wilson, A. S., Brankov, M. and Rakoczy, P. E. (2003). Oligonucleotide gene therapy for choroidal neovascularisation enhanced by dendrimer mediated delivery. 3rd Meeting of the Australasian-Gene-Therapy-Society, Brisbane Australia, Apr 30-May 02, 2003. CHICHESTER: Wiley. |